Defining a threshold for safe surgical management of vena cava thrombus in renal cell carcinoma patients: evidence from German total population data with 3,700 cases from 2006 to 2020

• by Thomas Martin, Johannes Huber, Rainer Koch, Marius Butea-Bocu, Lennard Haak, Luka Flegar, Matthias Giese, Fabian Kormann, Cem Aksoy, Aristeidis Zacharis, Christer Groeben

• November 29, 2024

International Kidney Cancer Collaboration with Leadership from Philadelphia

Kidney cancer is a growing global health problem, and both clinicians and policymakers need to prepare for a steep rise in the number of cases,” said Alexander Kutikov, MD, FACS, Chair of the Department of Urology at Fox Chase Cancer Center, and senior author of a landmark international study published in European Urology, which demonstrates that if current trends continue, kidney cancer cases could double by 2050

• by

• December 2, 2025

• 3 min

Consensus Guidelines for the Management of Locally Advanced and Metastatic Renal Cell Carcinoma by the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology for 2025

• by Darren M. C. Poon, Philip W. K. Kwong, Samson Y. S. Chan, Brian S. H. Ho, Martin H. C. Lam, K. S. Law, Angus K. C. Leung, Clarence L. H. Leung, David K. W. Leung, W. K. Ma, Barry B. W. Wo, Kenneth C. W. Wong, Philip Y. Wu, Peter K. F. Chiu

• April 23, 2026

Fox Chase Cancer Center and Temple Researchers Highlight Need for Molecular Testing in Diagnosing Two Types of Kidney Cancer

Genetic testing may be the most effective way for researchers to distinguish between a rare form of kidney cancer and another that is more common, potentially preventing misdiagnoses, according to a recent study by researchers at Fox Chase Cancer Center and Temple University Hospital.

• by

• October 8, 2025

• 3 min